Neuropsychological functioning following surgery for pediatric low-grade glioma: a prospective longitudinal study.
BRIEF = Behavior Rating Inventory of Executive Function
CPT = Continuous Performance Test
D-KEFS = Delis-Kaplan Executive Function System
FSIQ = Full Scale IQ
LGG = low-grade glioma
PRI = Perceptual Reasoning Index
PSI = Processing Speed Index
VCI = Verbal Comprehension Index
WISC-V = Wechsler Intelligence Scale for Children, Fifth Edition
WMI = Working Memory Index
brain tumor
executive functioning
low-grade glioma
neuropsychology
oncology
pediatric
surgery only
Journal
Journal of neurosurgery. Pediatrics
ISSN: 1933-0715
Titre abrégé: J Neurosurg Pediatr
Pays: United States
ID NLM: 101463759
Informations de publication
Date de publication:
06 Dec 2019
06 Dec 2019
Historique:
received:
18
06
2019
accepted:
16
09
2019
entrez:
8
12
2019
pubmed:
8
12
2019
medline:
8
12
2019
Statut:
aheadofprint
Résumé
High survival rates have led to an increased emphasis on the functional outcomes of children diagnosed with low-grade glioma. Most outcomes research has focused on risks associated with radiotherapy, but less is known about neuropsychological risks for patients treated with surgery alone. Here, the authors sought to examine the neuropsychological trajectories of children diagnosed with a low-grade glioma and monitored up to 6 years postsurgery. Secondarily, they explored demographic and clinical predictors of neuropsychological performance. The neuropsychological functioning of 32 patients (median age at diagnosis 10.0 years) was prospectively assessed annually for up to 6 years after surgery (median days from surgery at baseline = 72). Tumor location was predominately supratentorial (65.6%). A combination of performance-based and parent-reported measures was used to assess intelligence, memory, executive functioning, and fine motor control in all patients. Binomial tests at the postoperative baseline revealed that the proportion of children falling below the average range (< 16th percentile) was significantly higher than the rate expected among healthy peers on measures of verbal memory, processing speed, executive functioning, and fine motor control (p < 0.05). Even so, linear mixed models indicated that neuropsychological functioning at the postoperative baseline did not significantly change over time for up to 6 years after surgery across all domains. A larger tumor size was associated with a slower reaction time (p < 0.01). A supratentorial tumor location and history of seizures were associated with more parent-reported executive difficulties (p < 0.01). While radiotherapy is a known risk factor for neuropsychological deficits in pediatric brain tumor patients, findings in this study indicate that children treated for low-grade glioma with surgery alone (without radiotherapy or chemotherapy) remain susceptible to difficulties with memory, executive functioning, and motor functioning that persist over time. Over half of the children in the study sample required school support services to address neuropsychological weaknesses. Although low-grade glioma is often conceptualized as a benign tumor, children treated for this lesion require ongoing monitoring and intervention to address neuropsychological weaknesses resulting from the tumor itself as well as the surgery.
Identifiants
pubmed: 31812134
doi: 10.3171/2019.9.PEDS19357
pii: 2019.9.PEDS19357
pmc: PMC9040333
mid: NIHMS1794945
doi:
pii:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-9Subventions
Organisme : NCI NIH HHS
ID : K07 CA157923
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA187202
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA221197
Pays : United States
Références
Neurosurgery. 2011 Jun;68(6):1548-54; discussion 1554-5
pubmed: 21368693
Epilepsy Behav. 2005 May;6(3):337-41
pubmed: 15820340
J Clin Oncol. 2005 Aug 1;23(22):5198-204
pubmed: 16051961
J Neurooncol. 1996 Oct;30(1):61-9
pubmed: 8865004
J Clin Oncol. 2008 Oct 10;26(29):4765-70
pubmed: 18779602
Neuroimage. 2008 Aug 15;42(2):1032-44
pubmed: 18602840
Pediatrics. 2011 Mar;127(3):e639-46
pubmed: 21300680
Epilepsia. 2011 May;52(5):857-69
pubmed: 21426331
J Clin Exp Neuropsychol. 1998 Apr;20(2):245-58
pubmed: 9777479
J Neurol Neurosurg Psychiatry. 2004 Aug;75(8):1112-8
pubmed: 15258211
Psychol Sci. 2006 Jan;17(1):74-81
pubmed: 16371147
Pediatr Blood Cancer. 2009 Sep;53(3):417-23
pubmed: 19479971
Dev Neurorehabil. 2018 Aug;21(6):415-422
pubmed: 28968151
Pediatrics. 2008 Jun;121(6):e1686-95
pubmed: 18519472
Dev Disabil Res Rev. 2008;14(3):196-202
pubmed: 18924158
J Neurosurg. 2004 Nov;101(2 Suppl):159-68
pubmed: 15835103
J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):901-7
pubmed: 12810776
Pediatr Blood Cancer. 2014 Jul;61(7):1173-9
pubmed: 24482038
Neuropsychology. 2005 May;19(3):362-370
pubmed: 15910122
Pediatr Rehabil. 2004 Jan-Mar;7(1):1-14; discussion 15-6
pubmed: 14744668
Brain. 2000 May;123 ( Pt 5):1041-50
pubmed: 10775548
Neurosurgery. 2000 Aug;47(2):324-33; discussion 333-4
pubmed: 10942005
Neuro Oncol. 2018 Oct 1;20(suppl_4):iv1-iv86
pubmed: 30445539
Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):217-223.e1
pubmed: 22541967
J Clin Oncol. 2009 Aug 1;27(22):3691-7
pubmed: 19581535
Dev Med Child Neurol. 2010 Apr;52(4):386-93
pubmed: 19694778
Med Pediatr Oncol. 2003 Jan;40(1):26-34
pubmed: 12426683
J Neurooncol. 2019 Jan;141(2):413-420
pubmed: 30467811